EXPERIENCE WITH SGLT2 INHIBITORS.

Předmět:
Zdroj: Diabetes; 2015 Supplement, Vol. 64, pA27-A29, 3p, 4 Charts, 2 Graphs
Abstrakt: The article presents abstracts on medical topics, which include a study on the maintenance of weight loss with dapagliflozin vs. Glipizide as add-on to metformin in people with type 2 diabetes (T2DM), a study on the effect of saxagliptin as add-on to Dapagliflozin and metformin against T2DM, and a study on the long-term safety and effectiveness of Dapagliflozin in patients with T2DM and cardiovascular disease.
Databáze: Complementary Index